Back

Ten-year major clinical outcomes between first- and second-generation drug-eluting stents in hypertensive patients underwent percutaneous coronary intervention

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Hypertension in special circumstances Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Soohyung Park

Korea University Guro Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
HbA1c variability and macrovascular benefits of intensive blood pressure control in patients with type 2 diabetes
Doctor J. Pei (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Social determinants of health, blood pressure classification, and incident stroke in community-dwelling adults: a prospective cohort study
Professor Z. Nie (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Exploring the association between hypertension and atherosclerotic cardiovascular disease in adults with familial hypercholesterolemia: insights from the HELLAS-FH registry
Professor E. Liberopoulos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Bevacizumab-induced hypertension in patients with glioblastoma: a systematic review and meta-analysis
Miss A. Machado Silva (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Intensive blood pressure lowering after endovascular thrombectomy in acute ischaemic stroke: an updated systematic review and meta-analysis of randomized controlled trials
Doctor S. Mactaggart (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension in special circumstances

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Ten-year major clinical outcomes between first- and second-generation Drug-Eluting Stents in unstable angina patients underwent Percutaneous Coronary Intervention
thumbnail
Congress Presentation
Impact of 2nd-generation versus 3rd-generation beta-blockers on long-term clinical outcomes in STEMI patients treated with drug-eluting stents
thumbnail
Congress Presentation
Comparison of target vessel revascularization rates between biodegradable and durable polymer drug-eluting stents: a retrospective study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources